• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mTOR 信号相关 miRNAs 在心血管疾病中的新兴作用。

Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.

机构信息

Pauley Heart Center, Department of Internal Medicine, Division of Cardiology, Virginia Commonwealth University, Richmond, VA 23298, USA.

出版信息

Oxid Med Cell Longev. 2018 Aug 23;2018:6141902. doi: 10.1155/2018/6141902. eCollection 2018.

DOI:10.1155/2018/6141902
PMID:30305865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6165581/
Abstract

Mechanistic/mammalian target of rapamycin (mTOR), an atypical serine/threonine kinase of the phosphoinositide 3-kinase- (PI3K-) related kinase family, elicits a vital role in diverse cellular processes, including cellular growth, proliferation, survival, protein synthesis, autophagy, and metabolism. In the cardiovascular system, the mTOR signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of both physiological and pathological processes. MicroRNAs (miRs), a class of short noncoding RNA, are an emerging intricate posttranscriptional modulator of critical gene expression for the development and maintenance of homeostasis across a wide array of tissues, including the cardiovascular system. Over the last decade, numerous studies have revealed an interplay between miRNAs and the mTOR signaling circuit in the different cardiovascular pathophysiology, like myocardial infarction, hypertrophy, fibrosis, heart failure, arrhythmia, inflammation, and atherosclerosis. In this review, we provide a comprehensive state of the current knowledge regarding the mechanisms of interactions between the mTOR signaling pathway and miRs. We have also highlighted the latest advances on mTOR-targeted therapy in clinical trials and the new perspective therapeutic strategies with mTOR-targeting miRs in cardiovascular diseases.

摘要

机械论/哺乳动物雷帕霉素靶蛋白(mTOR)是一种非典型丝氨酸/苏氨酸激酶,属于磷酸肌醇 3-激酶(PI3K)相关激酶家族,在多种细胞过程中发挥重要作用,包括细胞生长、增殖、存活、蛋白质合成、自噬和代谢。在心血管系统中,mTOR 信号通路整合了细胞内和细胞外信号,是生理和病理过程的中央调节剂。微小 RNA(miRs)是一类短的非编码 RNA,是一种新兴的复杂的转录后调节因子,对广泛组织(包括心血管系统)的发育和稳态维持的关键基因表达具有重要作用。在过去的十年中,大量研究揭示了 miRNA 和 mTOR 信号通路在心肌梗死、肥大、纤维化、心力衰竭、心律失常、炎症和动脉粥样硬化等不同心血管病理生理学中的相互作用。在这篇综述中,我们全面介绍了 mTOR 信号通路与 miRNA 之间相互作用的机制。我们还强调了 mTOR 靶向治疗在临床试验中的最新进展,以及利用 mTOR 靶向 miR 治疗心血管疾病的新视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/cb510524c370/OMCL2018-6141902.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/12a8dc82b8a5/OMCL2018-6141902.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/123f0689bc39/OMCL2018-6141902.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/cb510524c370/OMCL2018-6141902.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/12a8dc82b8a5/OMCL2018-6141902.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/123f0689bc39/OMCL2018-6141902.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15ad/6165581/cb510524c370/OMCL2018-6141902.003.jpg

相似文献

1
Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.mTOR 信号相关 miRNAs 在心血管疾病中的新兴作用。
Oxid Med Cell Longev. 2018 Aug 23;2018:6141902. doi: 10.1155/2018/6141902. eCollection 2018.
2
Emerging Role of MicroRNAs in mTOR Signaling.微小RNA在mTOR信号通路中的新兴作用
Cell Mol Life Sci. 2017 Jul;74(14):2613-2625. doi: 10.1007/s00018-017-2485-1. Epub 2017 Feb 25.
3
Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets.mTOR 信号网络中的长非编码 RNA:生物标志物和治疗靶点。
Apoptosis. 2018 Jun;23(5-6):255-264. doi: 10.1007/s10495-018-1453-z.
4
The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses.microRNA 在调节免疫和炎症反应中的 mTOR 信号通路中的新兴作用。
Immunol Cell Biol. 2021 Sep;99(8):814-832. doi: 10.1111/imcb.12477. Epub 2021 Jun 15.
5
Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.哺乳动物雷帕霉素靶蛋白(mTOR)作为各种疾病的潜在治疗靶点。
Inflammopharmacology. 2017 Jun;25(3):293-312. doi: 10.1007/s10787-017-0336-1. Epub 2017 Apr 17.
6
The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.雷帕霉素靶蛋白(mTOR)在肺纤维化中的作用。
Int J Mol Sci. 2018 Mar 8;19(3):778. doi: 10.3390/ijms19030778.
7
New Insights Into the Role of mTOR Signaling in the Cardiovascular System.mTOR 信号在心血管系统中的作用的新见解。
Circ Res. 2018 Feb 2;122(3):489-505. doi: 10.1161/CIRCRESAHA.117.311147.
8
MicroRNA in cardiovascular biology and disease.心血管生物学与疾病中的微小RNA
Adv Clin Exp Med. 2017 Aug;26(5):865-874. doi: 10.17219/acem/62915.
9
Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway.多酚类物质在心血管疾病中的治疗潜力:调控 mTOR 信号通路。
Pharmacol Res. 2020 Feb;152:104626. doi: 10.1016/j.phrs.2019.104626. Epub 2020 Jan 2.
10
MicroRNA-761 inhibits Angiotensin II-induced vascular smooth muscle cell proliferation and migration by targeting mammalian target of rapamycin.微小RNA-761通过靶向雷帕霉素哺乳动物靶蛋白抑制血管紧张素II诱导的血管平滑肌细胞增殖和迁移。
Clin Hemorheol Microcirc. 2015 Sep 25;63(1):45-56. doi: 10.3233/CH-151981.

引用本文的文献

1
miRNA regulation of the Akt/mTOR pathway in oral squamous cell carcinoma: a focused review.微小RNA对口腔鳞状细胞癌中Akt/mTOR信号通路的调控:一项聚焦综述
Discov Oncol. 2025 Jul 17;16(1):1355. doi: 10.1007/s12672-025-03073-2.
2
Homocysteine Attack on Vascular Endothelium-Old and New Features.同型半胱氨酸对血管内皮的攻击——新老特征
Int J Mol Sci. 2025 Jun 30;26(13):6298. doi: 10.3390/ijms26136298.
3
Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy.

本文引用的文献

1
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes.急性冠状动脉综合征患者中依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架治疗结局的荟萃分析比较。
Am J Cardiol. 2018 Jul 1;122(1):61-68. doi: 10.1016/j.amjcard.2018.03.003. Epub 2018 Mar 27.
2
Insulin-mimetic effects of short-term rapamycin in type 1 diabetic patients prior to islet transplantation.短期雷帕霉素在胰岛移植前 1 型糖尿病患者中的胰岛素模拟作用。
Acta Diabetol. 2018 Jul;55(7):715-722. doi: 10.1007/s00592-018-1141-z. Epub 2018 Apr 13.
3
三七皂苷R1和柴胡皂苷B2在动脉粥样硬化中的协同作用:一种靶向PI3K/AKT/mTOR通路和巨噬细胞自噬的新方法。
PLoS One. 2025 Jun 27;20(6):e0326687. doi: 10.1371/journal.pone.0326687. eCollection 2025.
4
Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease.同型半胱氨酸代谢物、内皮功能障碍与心血管疾病
Int J Mol Sci. 2025 Jan 16;26(2):746. doi: 10.3390/ijms26020746.
5
Small Extracellular Vesicles Isolated from Cardiac Tissue Matrix or Plasma Display Distinct Aging-Related Changes in Cargo Contributing to Chronic Cardiovascular Disease.从心脏组织基质或血浆中分离出的小细胞外囊泡在促成慢性心血管疾病的货物中表现出与衰老相关的明显变化。
bioRxiv. 2024 Dec 12:2024.12.06.627231. doi: 10.1101/2024.12.06.627231.
6
mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma.mTOR 信号通路:在乙型肝炎病毒感染和肝细胞癌中的作用。
Int J Biol Sci. 2024 Aug 1;20(11):4178-4189. doi: 10.7150/ijbs.95894. eCollection 2024.
7
Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits.雷帕霉素诱导糖尿病兔缺血/再灌注损伤心肌保护作用的 lncRNA-miRNA-mRNA 调控网络的综合分析。
Cells. 2023 Dec 12;12(24):2820. doi: 10.3390/cells12242820.
8
mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy.mTORC1 与 SGLT2 抑制剂:治疗糖尿病心肌病的新策略
Int J Mol Sci. 2023 Oct 11;24(20):15078. doi: 10.3390/ijms242015078.
9
Effective Attenuation of Arteriosclerosis Following Lymphatic-Targeted Delivery of Hyaluronic Acid-Decorated Rapamycin Liposomes.基于透明质酸修饰的雷帕霉素脂质体淋巴靶向递释抑制动脉粥样硬化的作用
Int J Nanomedicine. 2023 Aug 2;18:4403-4419. doi: 10.2147/IJN.S410653. eCollection 2023.
10
Recent advances of the mammalian target of rapamycin signaling in mesenchymal stem cells.雷帕霉素哺乳动物靶点信号通路在间充质干细胞中的最新进展
Front Genet. 2022 Aug 30;13:970699. doi: 10.3389/fgene.2022.970699. eCollection 2022.
MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1.
miR-223 通过靶向 PARP-1 保护新生大鼠心肌细胞和 H9c2 细胞免于缺氧诱导的凋亡和过度自噬,通过 Akt/mTOR 通路。
J Mol Cell Cardiol. 2018 May;118:133-146. doi: 10.1016/j.yjmcc.2018.03.018. Epub 2018 Mar 31.
4
Cryo-EM structure of human mTOR complex 2.人源 mTOR 复合物 2 的冷冻电镜结构
Cell Res. 2018 May;28(5):518-528. doi: 10.1038/s41422-018-0029-3. Epub 2018 Mar 22.
5
Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: A Clinical Trial.依维莫司联合内分泌治疗用于雌激素受体阳性、人表皮生长因子受体 2 阴性的绝经后晚期乳腺癌:一项临床试验。
JAMA Oncol. 2018 Jul 1;4(7):977-984. doi: 10.1001/jamaoncol.2018.0060.
6
mTOR signaling-related MicroRNAs and Cancer involvement.与mTOR信号传导相关的微小RNA与癌症的关系
J Cancer. 2018 Jan 8;9(4):667-673. doi: 10.7150/jca.22119. eCollection 2018.
7
Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.西罗莫司治疗常规药物治疗抵抗或不耐受的活动性系统性红斑狼疮患者的单臂、开放标签、1/2 期临床试验。
Lancet. 2018 Mar 24;391(10126):1186-1196. doi: 10.1016/S0140-6736(18)30485-9. Epub 2018 Mar 15.
8
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial.沃克替尼(XL765)用于复发或难治性非霍奇金淋巴瘤或慢性淋巴细胞白血病患者:一项开放标签的2期试验。
Lancet Haematol. 2018 Apr;5(4):e170-e180. doi: 10.1016/S2352-3026(18)30030-9. Epub 2018 Mar 14.
9
Clinical development of voxtalisib: a pan-PI3K/mTOR inhibitor.沃克替尼(一种泛PI3K/mTOR抑制剂)的临床开发
Lancet Haematol. 2018 Apr;5(4):e134-e135. doi: 10.1016/S2352-3026(18)30034-6. Epub 2018 Mar 14.
10
TSC2 regulates microRNA biogenesis via mTORC1 and GSK3β.TSC2 通过 mTORC1 和 GSK3β 调节 microRNA 的生物发生。
Hum Mol Genet. 2018 May 1;27(9):1654-1663. doi: 10.1093/hmg/ddy073.